Defect in apoptotic signaling and up-regulation of drug transporters in
cancer cells significantly limits the effectiveness of
cancer chemotherapy. We propose that an agent inducing non-apoptotic cell death may overcome
cancer drug resistance and showed that
shikonin, a naturally occurring
naphthoquinone, induced a cell death in MCF-7 and HEK293 distinct from apoptosis and characterized with (a) a morphology of necrotic cell death; (b) loss of plasma membrane integrity; (c) loss of mitochondrial membrane potentials; (d) activation of autophagy as a downstream consequence of cell death, but not a contributing factor; (e) elevation of
reactive oxygen species with no critical roles contributing to cell death; and (f) that the cell death was prevented by a small molecule,
necrostatin-1, that specifically prevents cells from necroptosis. The characteristics fully comply with those of necroptosis, a basic cell-death pathway recently identified by Degterev et al. with potential relevance to human pathology. Furthermore, we proved that
shikonin showed a similar potency toward drug-sensitive
cancer cell lines (MCF-7 and HEK293) and their drug-resistant lines overexpressing
P-glycoprotein, Bcl-2, or Bcl-x(L), which account for most of the clinical
cancer drug resistance. To our best knowledge, this is the first report to document the induction of necroptosis by a small molecular compound to circumvent
cancer drug resistance.